Combyne, the made-in-Canada grain marketing platform Bayer bought earlier this year, is now fully on speaking terms with the company’s Climate FieldView precision ag platform. Bayer on Oct. 30 announced integration of the two platforms, which it said will allow grain farmers in Canada and the U.S. to connect their marketing data in Combyne and […] Read more

Bayer’s crop marketing, crop production platforms in sync
FieldView, Combyne platforms now integrated

Appeals court blocks California warning labels for glyphosate
Decision important in ongoing lawsuits, Bayer says
Reuters — A divided U.S. federal appeals court on Tuesday said California cannot require businesses to warn consumers about the potential dangers of glyphosate, an ingredient in Roundup herbicide that has been linked to cancer. Upholding a permanent injunction, the Ninth U.S. Circuit Court of Appeals in San Francisco found it unconstitutional to force Bayer’s […] Read more

Bayer slashes outlook as glyphosate demand weakens further
Analysts say dry weather conditions hurt farmers' demand for seeds and pesticides
Reuters – Further deterioration in demand for glyphosate-based weed killers led Bayer BAYGn.DE to cut its full-year earnings outlook and announce a 2.5 billion euro ($2.8 billion USD) write-down on glyphosate-related assets. In an unscheduled statement late on Monday, the German drugs and pesticides maker said it was projecting 2023 earnings before interest, taxes, depreciation […] Read more

Bayer settles with New York over Roundup safety claims
Company blocked from advertising product as non-toxic
New York | Reuters — Bayer agreed on Thursday to pay US$6.9 million to settle claims by New York Attorney General Letitia James that it misled consumers by advertising Roundup, which has been linked to cancer, as environmentally safe. The settlement resolves accusations that Bayer and its Monsanto unit failed to substantiate their repeated claims […] Read more

Bayer under investor pressure to speed up CEO changeover
Drug and chem firm's stock in 'crisis of trust,' investor says
Frankfurt | Reuters — A top-10 shareholder in Bayer on Tuesday called on the group’s supervisory board to replace CEO Werner Baumann quickly, adding to investor pressure to restore trust and revive the German drugmaker’s sagging share price. Despite recent improvements in the company’s agriculture business and drug development prospects, Bayer shares have been weighed […] Read more

Activist investor reported building stake in Bayer, seeking breakup
Bayer up for 'constructive dialogue'
Reuters — Activist investor Bluebell Capital Partners has built a stake in Bayer AG and is pushing for a breakup of the German pharmaceutical and agriculture company, Bloomberg reported on Tuesday, citing sources. U.K.-based Bluebell is also seeking an overhaul of Bayer’s corporate governance, the report added. A Bayer spokesperson, who declined to comment on […] Read more

Bayer’s agriculture unit, consumer health drive outlook hike
Frankfurt | Reuters – Agriculture and pharmaceuticals company Bayer BAYGn.DE on Thursday lifted its 2022 earnings guidance on strong demand from farmers for its seeds and crop chemicals and higher sales of consumer health products. Bayer is now targeting earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for special items, of about 13 billion […] Read more

Bayer, BASF win new trial on damage award in U.S. dicamba suit
Reuters — Bayer and BASF have won a new trial on US$60 million in punitive damages they were ordered to pay a Missouri peach farmer who said dicamba, a herbicide they produced, drifted onto his orchard and harmed his crops. The Eighth U.S. Circuit Court of Appeals found that a federal jury was wrongly told […] Read more

U.S. Supreme Court again nixes Bayer challenge to weedkiller suits
Washington | Reuters – The U.S. Supreme Court on Monday rejected another Bayer AG BAYGn.DE bid to dismiss litigation alleging that its Roundup weedkiller causes cancer as the German pharmaceutical and chemical giant tries to avoid potentially billions of dollars in damages. The justices turned away a Bayer appeal and left in place a lower […] Read more

U.S. Supreme Court rejects Bayer bid to toss Roundup suits
Washington | Reuters — The U.S. Supreme Court on Tuesday rejected Bayer’s bid to dismiss legal claims by customers who contend its Roundup herbicide causes cancer as the German company seeks to avoid potentially billions of dollars in damages. The justices turned away a Bayer appeal and left in place a lower court decision that […] Read more